Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03623464 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

RCT of Mobile Apps & FitBit v. Usual Care

StatusSuspended
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Active, Not Recruiting → Suspended Sponsor's reason: Study is paused for interim analysis.
    • Primary and study completion pushed from Jun 2026 to Mar 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 4 of 4 entries
  2. Primary and study completion dates: Aug 2025 to Jun 2026v10
  3. Primary and study completion dates: Feb 2025 to Aug 2025v9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 316 to confirmed 107
    • Site details revised
    v8
  5. Primary completion date: Aug 2025 to Feb 2025
    • Study completion date: Aug 2026 to Feb 2025
    • Site contact updated
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Re-verified, no change to tracked fieldsv6
  2. Primary completion date: Aug 2022 to Aug 2025
    • Study completion date: Aug 2023 to Aug 2026
    v5
  3. Enrollment target: 135 to 316
    • Primary completion date: Oct 2021 to Aug 2022
    • Primary endpoint revised
    • Study completion date: May 2022 to Aug 2023
    v4
  4. Primary endpoints: 2 to 1v3 Show 4 more changesShow less
    • Primary completion date: Jun 2021 to Oct 2021
    • Study completion date: Dec 2021 to May 2022
    • Secondary endpoints: 3 to 4
    • Collaborators expanded, about 5 words
  5. Primary completion date: Jun 2019 to Jun 2021v2 Show 4 more changesShow less
    • Primary endpoints revised (2)
    • Study completion date: Dec 2019 to Dec 2021
    • Secondary endpoints: details revised at 1 of 3 entries
    • Eligibility criteria expanded, about 1 word
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Weill Medical College of Cornell University
237 trials monitored
See 18 trials at risk
Colorectal Cancer
3,394 trials monitored
See 159 trials at risk
Pancreatic Cancer
1,739 trials monitored
See 106 trials at risk
Liver Cancer
1,598 trials monitored
See 71 trials at risk
and 1 more disease
This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.
Trial Details
NCT Number NCT03623464
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Damon Runyon Cancer Research Foundation
Conditions
(from sponsor)		 Pancreatic Cancer, Gastric Cancer, Hepatic Cancer, Colon Cancer, Rectal Cancer, Small Bowel Cancer
Related terms Colonic Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms
Enrollment 107 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov